Register entry
Putian Longrust Environmental Protection Technology Co LTD
Data as of · How to read this entry
- Registered sites
- 1
- Active NDC listings
- 0
- Live patents
- 0
- Countries
- 1
- Base
- China
Authorisation
Registered operations
Finished drug manufacture1Relabelling1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| Putian Longrust Environmental Protection Technology Co., LTDRegistrant: Putian Longrust Environmental Protection Technology Co LTD | Rm. 402, Ladder 1, Bldg. 3, No. 318 Liyuan South Rd., Gongchen St., Licheng Dist.,, Putian, Fujian, China (CHN) | Finished drug manufacture, Relabelling | 3037095793602114248 |
Neighbours
Registered in the same town
3- Fujian Genohope Biotech Ltd.Putian, CHN
- Fujian Yifa Healthcare Products Co., Ltd.Putian, CHN
- Putian Licheng District Zhijiancheng Trading Co., Ltd.Putian, CHN
Compare
Comparable companies in China
- Kingkey MBC Life Technology Group co., LTD.1 site · 158 NDC
- Zhejiang Guoyao Jingyue Aerosol Co Ltd1 site · 94 NDC
- Shenzhen iShan Technology Co Ltd1 site · 84 NDC
- Xiamen Kang Zhongyuan Biotechnology Co., Ltd.1 site · 68 NDC
- Changzhou Maokang Medical Products Co., Ltd1 site · 59 NDC
- Jianerkang Medical Co Ltd1 site · 56 NDC
- Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd1 site · 40 NDC
- Guangdong Aimu Biological Technology Co Ltd1 site · 39 NDC
- Shenzhen Xinxin Yunhai Technology Co., Ltd.1 site · 37 NDC
- Guangdong Quadrant Ecological Technology Co., Ltd.1 site · 35 NDC
Enquiry
Common questions
- Is Putian Longrust Environmental Protection Technology Co LTD FDA approved?
- Putian Longrust Environmental Protection Technology Co LTD holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are Putian Longrust Environmental Protection Technology Co LTD's drugs manufactured?
- The FDA register lists Putian. Registered operations: finished drug manufacture, relabelling.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.